Literature DB >> 22991115

Prevalence of alcohol, tobacco and street drugs consumption in adult Latin American immigrants.

José Rafael González-López1, María de Los Ángeles Rodríguez-Gázquez, María de Las Mercedes Lomas-Campos.   

Abstract

To estimate the prevalence of alcohol, tobacco and illicit drug consumption (through the self-report) in adult Latin-American immigrants of Seville, a cross-sectional descriptive study was carried out in a representative sample of 190 immigrants. The results showed that 61.4% of the participants had consumed alcohol in previous month before data collection, although 13.2% of them were at risk of alcoholism. Moreover, 30.0% were smokers. In addition, 5.3% of the interviewed people had consumed illicit psychoactive substances in the previous six months (Marihuana: 3.7%, hashish: 1.1% and cocaine: 0.5%). For all substances under analysis, the consumption prevalence was much higher in men from 25 to 39 years of age. In conclusion, prevalence levels of this consumption were high among the studied immigrants. Nurses could train the population in the prevention of these risk behaviors through preventive practices.

Entities:  

Mesh:

Year:  2012        PMID: 22991115     DOI: 10.1590/s0104-11692012000300014

Source DB:  PubMed          Journal:  Rev Lat Am Enfermagem        ISSN: 0104-1169


  3 in total

1.  Immigration experience of Latin American working women in Alicante, Spain: an ethnographic study.

Authors:  Liliana González-Juárez; Ana Lucía Noreña-Peña; Luis Cibanal-Juan
Journal:  Rev Lat Am Enfermagem       Date:  2014-10

Review 2.  Hispano-Americans in Europe: what do we know about their health status and determinants? A scoping review.

Authors:  Maria Roura; Andreu Domingo; Juan M Leyva-Moral; Robert Pool
Journal:  BMC Public Health       Date:  2015-05-07       Impact factor: 3.295

3.  Indicators of psychiatric disorders in different oncology specialties: a prevalence study.

Authors:  Manuela Polidoro Lima; Flávia L Osório
Journal:  J Oncol       Date:  2014-04-14       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.